James Leal Tandem Diabetes Care Inc (TNDM) insider trading activity

James Leal is Chief Manufacturing Officer of TANDEM DIABETES CARE INC. Currently has a direct ownership of 16,876 shares of TNDM, which is worth approximately $624,580. The most recent transaction as insider was on Feb 15, 2023, when has been sold 79 shares (Common Stock) at a price of $43.11 per share, resulting in proceeds of $3,405. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.9K

0% 3M change

66.87% 12M change

Total Value Held $624,580

James Leal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2023	SELL Payment of exercise price or tax liability	$3,405 $43.11 p/Share	79 Reduced 1.38%	5,641 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	168 Added 2.85%	5,720 Common Stock
Nov 28 2022	SELL Payment of exercise price or tax liability	$5,456 $39.54 p/Share	138 Reduced 2.43%	5,552 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	-	310 Added 5.17%	5,690 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$3,170 $42.27 p/Share	75 Reduced 1.37%	5,380 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	-	167 Added 2.97%	5,455 Common Stock
Aug 29 2022	SELL Payment of exercise price or tax liability	$6,442 $46.68 p/Share	138 Reduced 2.54%	5,288 Common Stock
Aug 29 2022	BUY Exercise of conversion of derivative security	-	309 Added 5.39%	5,426 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$4,144 $55.25 p/Share	75 Reduced 1.44%	5,117 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	-	168 Added 3.13%	5,192 Common Stock
May 27 2022	SELL Payment of exercise price or tax liability	$9,772 $70.81 p/Share	138 Reduced 2.67%	5,024 Common Stock
May 27 2022	BUY Exercise of conversion of derivative security	-	310 Added 5.67%	5,162 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$22,007 $73.85 p/Share	298 Reduced 6.16%	4,542 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	-	670 Added 12.16%	4,840 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$18,963 $61.17 p/Share	310 Added 6.01%	4,852 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$16,640 $112.43 p/Share	148 Reduced 3.43%	4,170 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	310 Added 6.7%	4,318 Common Stock
Dec 27 2021	SELL Open market or private sale	$288,969 $151.61 p/Share	1,906 Reduced 32.23%	4,008 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$127,550 $66.92 p/Share	1,906 Added 24.37%	5,914 Common Stock
Nov 29 2021	SELL Payment of exercise price or tax liability	$19,968 $129.66 p/Share	154 Reduced 3.7%	4,008 Common Stock
Nov 29 2021	SELL Open market or private sale	$250,888 $131.7 p/Share	1,905 Reduced 32.22%	4,008 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	$98,811 $44.61 p/Share	2,215 Added 27.25%	5,913 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$7,008 $69.39 p/Share	101 Added 2.56%	3,852 Common Stock
Oct 27 2021	SELL Open market or private sale	$248,167 $130.34 p/Share	1,904 Reduced 33.67%	3,751 Common Stock
Oct 27 2021	BUY Exercise of conversion of derivative security	$127,416 $66.92 p/Share	1,904 Added 25.19%	5,655 Common Stock

James Leal

Chief Manufacturing Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNDM shares.

Notify only if

Value

Insider Trading

Get notified when an Tandem Diabetes Care Inc insider buys or sells TNDM shares.

Notify only if

Operation

Value

Type

News

Receive news related to TANDEM DIABETES CARE INC

Track Activities on TNDM

Account